Meyka AI API is live for developers.Start building.
Advertisement
GRAIL, Inc. Common Stock

GRAIL, Inc. Common Stock (GRALV) Stock Overview

Explore GRAIL, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

GRALVNASDAQ
HealthcareMedical - Diagnostics & Research
$18.63
$1.41(8.19%)
U.S. Market opens in 51h 57m
Advertisement

GRAIL, Inc. Common Stock (GRALV)

Meyka AI Score

Z

Key Financials

Market Cap579.4M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GRALV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GRAIL, Inc. Common Stock (GRALV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 579.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
6.52%
1-Month Change
N/A
3-Month Change
186299900.00%
6-Month Change
186299900.00%
Year-to-Date (YTD) Change
186299900.00%
1-Year Change
186299900.00%
3-Year Change
186299900.00%
5-Year Change
186299900.00%
All-Time (Max) Change
186299900.00%

Contact Information

833-694-2553
1525 O’Brien Drive, Menlo Park, CA, 94025

Company Facts

CountryUS

Frequently Asked Questions